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Background: The purpose of this study was to evaluate the outcome of pterygium excision 
with inferior conjunctival autografting for primary pterygium.
Methods: This was a prospective noncomparative interventional case series study enrolling 
50 eyes of 50 patients with primary pterygium between November 1, 2010 and October 30, 
2011. All patients underwent the standard surgical technique for pterygium excision with inferior 
conjunctival autografting. The sampling method was purposive. The study variables were 
complications of surgery and recurrence rates during a follow-up period of 6 months.
Results: The mean age of the patients was 43 ± 7.97 (range 26–64) years. Grade 1 pterygium 
comprised 64% while grade 2 pterygium comprised 36% of cases. The mean size of pterygium 
was 3.2 ± 0.60 mm. Minor complications did occur, but only 4% required resuturing.   Recurrence 
occurred in two eyes (4%) which we detected 3 months after surgery in both cases. We observed 
conjunctival scarring at the donor site in four eyes (8%); however, there was no symblepharon 
formation or restriction of upgaze.
Conclusion: Inferior conjunctival autografting is an effective technique with a low recurrence 
rate. This is a useful technique when it is not possible or desirable to use the superior conjunctiva 
as a donor source. It is an especially good option for preserving the glaucoma filtration site for 
the future.
Keywords: inferior, conjunctival, autografting, pterygium surgery, recurrence
Introduction
The prevalence of pterygium varies from country to country relative to proximity to 
the equator. It is more common in warm and dry climates. The prevalence of pterygium 
is 2%–7% in the US and 1.1% in Australia.1,2 The Beijing study showed the prevalence 
of pterygium to be 3%, while in Tehran its prevalence is 1.3%.3,4 It has a prevalence 
of 19.6% in those aged 40 years in rural Myanmar according to a population-based 
cross-sectional survey.5 However, in Nepal, there is no exact population-based study 
showing the prevalence of pterygium.
Pterygium is a degenerative ocular surface disorder with wing-shaped fibrovascular 
growth of the bulbar conjunctiva onto the cornea, which is strongly correlated with 
ultraviolet light exposure, dryness, exposure to wind, dust, and heat, and oncogenes 
or viruses. It is most common in the nasal site, suggesting possible light reflectivity 
from the nasal bridge over the pterygium site, but it can also occur in the temporal site. 
Destruction of Bowman’s layer by fibrovascular ingrowth, which causes mild inflam-
matory changes in the cornea as well as the conjunctiva, has been demonstrated. The 
epithelium may be normal, thick, or thin, but it may occasionally show dysplasia. 
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  Pterygium has a bimodal age distribution, occurring 
  particularly in the young and the elderly.1,6–8
Treatment of pterygium is surgical. In general, conser-
vative therapy for pterygium is warranted unless one of the 
following is present: loss of visual acuity because of 
induced astigmatism or encroachment onto the visual axis, 
marked cosmetic deformity, marked discomfort and irrita-
tion unrelieved by medical management, limitation of 
ocular motility secondary to restriction, or documented 
progressive growth toward the visual axis so that ultimate 
loss of vision can reasonably be assumed. In such circum-
stances, surgical intervention is required. The fact that 
numerous different techniques exist for the surgical treat-
ment of pterygium underscores the point that no single 
approach is universally successful.9
Susruta first described the surgical methods for pterygium 
in 1897. Since then, many authors have described a considerable 
number of surgical techniques for its   management. There are 
many surgical techniques, including pterygium excision with 
bare sclera, conjunctival autografting, amniotic membrane 
grafting, and adjuvant use of mitomycin C or thiotepa. However, 
recurrence-free surgery for pterygium continues to present a 
challenge. Kenyon and colleagues reported the first use of 
free conjunctival autografting for pterygium surgery in 1985.11 
Several large multicenter studies have shown that conjunctival 
autografting has a low recurrence rate, and in all these studies 
the graft was taken from the superior bulbar conjunctiva.10–18 
However, there is limited information available regarding the 
efficacy of a graft taken from the inferior conjunctiva. The 
purpose of this study was to determine the outcome of surgery 
using inferior conjunctival autografting and to address the 
importance of preserving the glaucoma filtration site.
Methodology
This was a prospective, noncomparative, interventional 
case series study enrolling 50 eyes of 50 patients with 
pterygium between November 1, 2010 and October 30, 
2011 at Geta Eye Hospital, Dhangadhi, Nepal. The sampling 
method was purposive. The study protocol was approved 
by the hospital institutional review committee. The patients 
were informed about the design of the study and procedure, 
and written informed consent was obtained from all 
patients. Only primary pterygium cases were included. 
Patients with a major systemic or ocular surface disease or 
a history of earlier ocular surgery or trauma were excluded. 
Best-corrected Snellen visual acuity, intraocular pressure, 
and details of slit-lamp and fundus examination were 
recorded before surgery.
We categorized pterygium as grade 1 if ,3.5 mm and grade 
2 if .3.5 mm in horizontal dimension. Indications for surgery 
were classified as symptomatic pterygium if causing redness 
or irritation on more than three occasions per year, visually 
threatening pterygium if very close to pupillary border, and 
cosmetic pterygium if small and the patient wanted surgery.
Surgical procedure
All of the patients underwent our standard surgical technique 
of pterygium excision followed by inferior conjunctival 
autografting. Three ophthalmologists performed the surgery 
under retrobulbar block using 3 mL of 2% xylocaine + epi-
nephrine 1:8000 + 1.5 mL of bupivacaine. After painting the 
lids and periocular area with 5% povidone iodine and draping, 
a lid speculum was applied. The head of the pterygium was 
dissected from the cornea using a No 11 blade, and its corpus 
and underlying Tenon’s capsule were trimmed using Westcott 
scissors up to 5 mm away from the limbus.   Subconjunctival 
fibrous tissue under the pterygium was excised much more 
widely than the area covered by the pterygium. The rough 
surface of the corneal bed was dissected with Colibri, and 
smoothed with a 20-gauge bevel up crescent blade. We took 
a roughly appropriate-sized graft of bare sclera from the adja-
cent inferior bulbar conjunctiva after blunt dissection of the 
conjunctiva without the Tenon’s capsule. This graft was rotated 
over the excised area and sutured with 8/0 Vicryl. The eye was 
patched and Ocupol-D® (chloramphenicol 10 mg + dexametha-
sone 1 mg/g) ointment was applied at the end of surgery.
Follow-up visits
After surgery, biomicroscopic examination was performed 
on the first day, and topical Pyrimon® (chloramphenicol 1% + 
dexamethasone 0.1%) eye drops were administered as one 
drop four times a day for the first week and tapered until one 
month. Patients also received Ocu-Mycin® (chloramphenicol 
1%) ointment at bedtime for the first 2 weeks. On postopera-
tive day 7, we removed residual sutures if present with plain 
forceps and Vannas scissors under topical anesthesia using 
4% xylocaine eye drops. If graft swelling was present at 
week 1 after surgery, suture removal was delayed until disap-
pearance of the swelling. We also examined the patients at 
months 1, 3, and 6 postoperatively, and evaluated for graft 
retraction, graft necrosis, suture granuloma, Tenon’s cyst, 
and recurrence. We followed the definition of recurrence as 
growth of fibrovascular tissue encroaching towards the 
  cornea from the limbus as described by Sebban and Hirst.19 
The main outcome measures were recurrence of pterygium 
and complications.
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Table 1 Demographic and basic characteristics of patients
Average age in years (SD) 43 (7.97)
Age in years (Range) 26–64
sex (No)
  Male 28
  Female 22
Occupation (%)
  Farmers 50
  Laborers 34
  Others 16
Pterygium (No of eyes)
  Grade 1 32
  Grade 2 18
Average size of Pterygium in mm (SD) 3.2 (0.60)
Abbreviations: sD, standard deviation; No, number.
Table 2 Risk factors for recurrence
No of  
patients
No of  
recurrence
Percentage
Age (years)
 , 40 14 2 14.28
 . 40 36 0 0
Gender
  Male 28 1 3.57
  Female 22 1 4.54
Occupation
  Outdoor 42  2 4.76
  Indoor 8 0 0
Grade
 1 32 1 3.12
 2 18 1 5.55
Abbreviation: No,  Number.
Table 3 Indications for surgery
Indications for surgery Frequency Percentage
Symptomatic 32 64
Vision threatening 4 8
Cosmetic 14 28
Total 50 100
Table 4 Postoperative complications
Postoperative complications No of eyes Percentage
Wound gap $ 0.05 mm 2 4 (required 
resuturing)
Graft edema 16 32
Retention cyst # 0.05 mm 3 6
Conjunctiva scarring 4 8
Recurrence 2 4
Statistical analysis
Data were entered into SPSS version 12 (SPSS Inc, Chicago, 
IL), and were expressed as the frequency, percentage, mean, 
standard deviation, and range, as applicable.
Results
We performed surgery on 58 eyes from 58 patients, but 
eight patients were lost to follow-up. Hence, in this study, 
we enrolled only 50 eyes from the 50 patients who com-
pleted the six months of follow-up. Demographic and 
baseline characteristics of the patients are shown in Table 1. 
Table 2 shows that patients in the younger age groups and 
those engaged in outdoor occupations had a tendency to 
recurrence of pterygium. Table 3 shows that most common 
indication for surgery was symptomatic pterygium.
Postoperative complications are shown in Table 4. Minor 
complications did occur, but only 4% required resuturing. 
Recurrence was detected at 3 months after surgery in two 
eyes (4%). We observed conjunctival scarring at the donor 
site in four eyes (8%); however, there was no symblepharon 
formation or restriction of upgaze.
Discussion
Various surgical techniques have been used to treat ptery-
gium. The diversity of techniques reflects the ongoing surgi-
cal challenge to devise the best method for treating pterygium. 
Many studies have been published with conflicting results. 
Our surgical technique aims to preserve the glaucoma filtra-
tion site and, unlike most of the other autoconjunctival 
techniques, the graft is taken from the inferior conjunctiva.
In our study, most patients were farmers (50%) and 
  laborers (34%) who have to work outside for long periods 
and are exposed to the hazardous effects of infrared and 
ultraviolet radiation present in sunlight. These findings are 
similar to those of most of the published studies.8,9,20 The 
indication for surgery in our study was mainly symptomatic 
pterygium. Nazzulah et al reported a similar indication.21
We detected recurrence in two (4%) of 50 eyes treated 
with inferior autografting in our series. In 1985, Kenyon et al11 
published a report describing conjunctival autografting as a 
promising technique in the treatment of pterygium. They 
documented a recurrence rate of 5.3% in the primary pterygium 
group. Since then, several papers on the success of conjunctival 
grafting have been published, with varying success rates.12–18 
Possible reasons for the wide variation in success of conjunc-
tival autografting in these studies include case selection bias 
by different surgeons, varying surgical techniques, and varia-
tion in ability on the part of individual surgeons.
Syam et al have described the success of pterygium 
  excision followed by inferior conjunctival autografting at a 
Sussex hospital in the UK. Surgery was performed by an 
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experienced surgeon in 23 patients and by trainees in the 
remaining four cases. The mean follow-up duration was 
27 (range 8–53) months. Recurrence was detected in one eye 
(3.3%). Conjunctival scarring was found at the donor site in 
11 eyes (36.6%). There was no symblepharon formation.22 
Our study showed a recurrence rate of 4% and our findings 
were similar for minor complications. The conjunctival scar-
ring rate at the donor site was only 8% in our series. This 
could be due to our short follow-up period.22 Complications 
resulting from inferior conjunctival autografting are not 
  serious and pose no threat to vision.
There has been a similar paper published by Kim et al. The 
procedure was performed by making a flap of the inferior 
conjunctiva after excision of the pterygium, and transposing 
it to make a covering for the bare sclera and donor site as a 
barrier to pterygium tissue. This method was used in 54 eyes 
from 50 patients of mean age 47 (range 18–69) years with 
primary pterygium. During a mean follow-up period of 20 
(range 12–26) months, the pterygium recurred in three (5.6%) 
of the 54 eyes. The authors concluded that the inferior con-
junctival transposition flap is a promising technique for treat-
ment of primary pterygium.23 Although our report shows a 
slightly better outcome in terms of recurrence than that report, 
we would need a more prolonged follow-up period to make a 
meaningful comparison of the results of these two studies.
Koc et al24 demonstrated that autografting from superior 
or inferior sites in primary pterygium cases showed no signifi-
cant difference in recurrence rate, but in the event of recurrent 
pterygia, autografting from the inferior site resulted in a sig-
nificantly (P = 0.166) higher likelihood of recurrence.
Sebban and Hirst19 reviewed 161 known pterygium recur-
rences to determine when these recurrences occurred. Their 
analysis of survival curves showed that there was a 50% chance 
of recurrence within the first 120 days and a 97% chance that 
there would be a recurrence by 12 months after surgery. In 
contrast with these findings, Ti et al25 reported that most recur-
rences following conjunctival autografting tend to occur within 
6 months of surgery. Generally, recurrences of pterygium also 
occur during the first 6 months after surgery as observed by 
Adamis et al.26 Our study has the shortcoming of a follow-up 
period of only 6 months. A larger-scale, longer-term study 
will be needed to identify the optimal follow-up period.
Guler et al reported a recurrence rate of 13.3% in patients 
under 40 years of age who were followed up after autograft 
transplantation.27 In contrast, the recurrence rate was reported 
to be highest (at 42.3%) in the 40–50-year age group in another 
series, with no statistically significant difference between 
groups younger or older than 40 years.28 Our study shows a 
tendency for pterygium recurrence in the younger age groups. 
There was a tendency for recurrence in patients younger than 
40 years, but this was not statistically  significant. Because 
this technique is safe and effective, inferior conjunctival 
autografting deserves better recognition.
Conclusion
Inferior conjunctival autografting is an effective technique with 
a low recurrence rate. It is a useful technique when it is not 
possible or desirable to use the superior conjunctiva as a donor 
source. In countries like Nepal where there is a lack of public 
awareness about the devastating effects of glaucoma, attendance 
and regular follow-up in the early stages of the disease at eye 
centers is very unlikely. Patients may have glaucoma and 
pterygium together, and surgeons may miss glaucoma in the 
early stages. It is also true that patients with glaucoma usually 
present to hospital at a late stage, when glaucoma filtration may 
be the only option, and even when the patient presents early 
on, they may need glaucoma surgery if medical therapy is 
unsuccessful. We can use the inferior bulbar conjunctiva safely 
and effectively for grafting in pterygium surgery as a surgical 
alternative for preserving the glaucoma filtration site in the 
future. We recommend further investigations in larger numbers 
of patients and for longer periods of follow-up to make this 
surgical method universally applicable.
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